Efficacy Evaluation of Dai Dai Flower on Body Weight
1 other identifier
interventional
50
1 country
1
Brief Summary
To assess the Dai Dai flower extract on body weight control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2020
CompletedStudy Start
First participant enrolled
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2021
CompletedAugust 4, 2021
August 1, 2021
2 months
December 29, 2020
August 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The change of body weight
The body weight (kg) was assessed by InBody.
Change from Baseline body weight at 8 weeks
The change of BMI
The BMI was assessed by InBody.
Change from Baseline BMI at 8 weeks
Secondary Outcomes (19)
The change of body fat mass
Change from Baseline body fat mass at 8 weeks
The change of visceral fat mass
Change from Baseline visceral fat mass at 8 weeks
The change of waist-hip ratio
Change from Baseline waist-hip ratio at 8 weeks
The change of basal metabolic rate
Change from Baseline basal metabolic rate at 8 weeks
The change of AST
Change from Baseline AST at 8 weeks
- +14 more secondary outcomes
Study Arms (2)
Placebo drink
PLACEBO COMPARATORDai Dai flower drink
EXPERIMENTALInterventions
consume 1 bottle (50 mL) per day for 8 weeks
Eligibility Criteria
You may qualify if:
- Healthy male or female aged between 20 and 60 years old
- Body mass index (BMI) ≥ 24 (kg/m\^2) or body fat mass ≥ 25%
You may not qualify if:
- Pregnant or breastfeeding woman
- Implementation in weight loss programs, consumption drugs or supplements for weight control before 3 months of this study
- Participate weight control or fat loss human studies before 3 months of this study
- History of cardiovascular disease, liver disease, kidney disease, endocrine disease, or other major organic diseases (according to subjects reporting).
- Person who has received major surgery or bariatric surgery (according to medical history).
- Person who has received constant drug use.
- People with mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TCI Co., Ltd.lead
Study Sites (1)
China Medical University
Taichung, 404, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hsiu-Mei Chiang, Prof.
China Medical University, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2020
First Posted
January 5, 2021
Study Start
January 4, 2021
Primary Completion
March 6, 2021
Study Completion
June 15, 2021
Last Updated
August 4, 2021
Record last verified: 2021-08